Decalepis arayalpathra

Names and Synonyms

Scientific Names

Accepted name

Synonyms

• Janakia arayalpathra

Sources: Wikidata

Taxonomical Classification

This plant belongs to the kingdom Plantae and is classified under the phylum Streptophyta and class Equisetopsida. Within the subclass Magnoliidae and order Gentianaales, it is further categorized into the family Apocynaceae. Ultimately, its taxonomic identity is defined by the genus Decalepis, specifically as the species Decalepis arayalpathra.

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

This plant, known scientifically as Decalepis arayalpathra, exhibits a specific and localized geographical range. Its natural occurrence is primarily documented within the vast expanse of the Indian Subcontinent. More specifically, the species is found growing natively across various regions of India. This distribution suggests that the plant is well-adapted to the particular climatic and soil conditions present in this part of Asia. Consequently, researchers focusing on its medicinal properties concentrate their studies within these Indian habitats.

Sources: The World Checklist of Vascular Plants (WCVP)

Chemicals

Decalepis arayalpathra has 16 reported phytochemicals identified across 0 scientific publications and several other databases. The most consistently reported chemicals include 2-Hydroxy-4-methoxybenzaldehyde, 2-hydroxy-4-methoxy-benzoic acid, 3-Hydroxy-4-methoxy-benzaldehyde, 3-Hydroxy-p-anisaldehyde, CINNAMIC ACID.

2-Hydroxy-4-methoxybenzaldehyde

1. Current pharmaceutical biotechnology
2. Natural product research

2-hydroxy-4-methoxy-benzoic acid

1. Journal of pharmaceutical and biomedical analysis

3-Hydroxy-4-methoxy-benzaldehyde

1. Current pharmaceutical biotechnology

3-Hydroxy-p-anisaldehyde

1. Current pharmaceutical biotechnology

CINNAMIC ACID

1. Current pharmaceutical biotechnology

HMB

1. Current pharmaceutical biotechnology

Magnificol

1. Current pharmaceutical biotechnology

Menthyl acetate

1. Current pharmaceutical biotechnology

P-ANISALDEHYDE

1. Current pharmaceutical biotechnology

P-CYMENE

1. Current pharmaceutical biotechnology

Activities

Decalepis arayalpathra has 2 reported activities identified across 0 scientific publications and several other databases. The most consistently reported activities include Antiinflammatory, Antipyretic.

Antiinflammatory

1. Current pharmaceutical biotechnology

Antipyretic

1. Current pharmaceutical biotechnology

Conditions

Decalepis arayalpathra has 7 reported investigations on conditions identified across 0 scientific publications and several other databases. The most consistently reported conditions include anti-oxidant, antipyretic, cancer, cough, inflammation.

Anti-oxidant

1. Current pharmaceutical biotechnology
2. Journal of pharmaceutical and biomedical analysis

Antipyretic

1. Current pharmaceutical biotechnology

Cancer

1. Current pharmaceutical biotechnology

Cough

1. Current pharmaceutical biotechnology

Inflammation

1. Current pharmaceutical biotechnology

Peptic ulcer

1. Natural product research

Wound healing

1. Current pharmaceutical biotechnology

Preparations

Decalepis arayalpathra has 2 reported preparations identified across 0 scientific publications and several other databases. The most consistently reported preparations include D. arayalpathra tubers, synthetic seed.

D. arayalpathra tubers

1. Current pharmaceutical biotechnology

Synthetic seed

1. BMC plant biology